Bulletin Contents
Search
Home Page
 
Marvel Biosciences Corp. 
Listed Company 

BULLETIN V2026-3177

MARVEL BIOSCIENCES CORP. ("MRVL")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: October 8, 2026
TSX Venture Tier 2 Company

Financing Type: Non-Brokered Private Placement

Gross Proceeds: $1,598,144.70

Offering: 10,654,298 Units with 10,654,298 Warrants attached

Offering Price: $0.15 per Unit

Warrant Exercise Terms: $0.20 per Listed Share for a 1-year period commencing on the 61st day after closing, subject to an acceleration right.

Commissions in Securities:
Finders (Aggregate)
Finder Shares
Finder Warrants
6 Finders
NIL
494,737




Commission Terms: Each non-transferable Finder Warrant is exercisable at $0.20 per Listed Share for a 1-year period commencing on the 61st day after closing, subject to an acceleration right.

Disclosure: Refer to the Company's news releases dated July 16, 2026, August 19, 2026, September 9, 2026 and September 29, 2026.
_______________________________________